IndiaOne Finance - Company Dashboard

Governance Classic Home

Wanbury LtdPharmaceuticalsINE107F01022Standalone₹222.75-0.90 (-0.40%)Jun-26

Valuation

Market Cap₹778.28 Cr

TTM PE12.83x

Forward PE13.07x

PEG-0.83

Book Value₹41.34

P/B5.39x

TTM EPS₹17.36

Fwd EPS₹17.04

TTM Revenue₹652.67 Cr

TTM PAT₹55.88 Cr

TTM EBITDA₹98.56 Cr

TTM EBIT₹83.85 Cr

Last Qtr PAT₹3.24 Cr

Last Qtr EBITDA₹16.23 Cr

Last Qtr EBIT₹12.19 Cr

Profitability

ROE38.68%

ROCE23.00%

TTM NPM8.56%

TTM EBITDA %15.10%

Curr OPM1.95%

Last OPM13.17%

Curr NPM—

Last NPM—

Curr EPS₹0.93

Last EPS₹7.33

Balance sheet

Equity₹34.94 Cr

Reserve₹109.51 Cr

Total Debt₹215.45 Cr

D/E1.49x

Interest %245.99%

Curr Interest₹7.97 Cr

Price / range

Close₹222.75

vs 52W High-37.93%

vs 52W Low+37.50%

MA50—

MA200—

Returns

1D-0.40%

1W-6.94%

1M-12.39%

3M-14.80%

6M-10.36%

1Y-14.06%

2Y-11.45%

3Y+273.68%

5Y+171.65%

Diwali-3.40%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	165.58+1.5%	164.58	162.45	160.06	163.18	650.27
Other Income	0.36	0.21	0.18	0.20	0.35	0.94
Total Income	165.94+1.5%	164.79	162.63	160.26	163.53	651.21
Interest	7.97	8.06	7.26	7.12	7.54	29.98
Expenditure	-161.36-7.6%	-146.01	-146.76	-145.10	-149.93	-587.80
PBDT	0	0	0	0	0	0
EBITDA	16.23-33.6%	29.86	26.69	25.78	24.43	106.76
Depreciation	-4.04	-3.23	-3.74	-3.70	-3.64	-14.31
EBIT	12.19-41.4%	26.63	22.95	22.08	20.79	92.45
PBT	4.59-66.3%	15.17	15.87	15.16	13.61	59.80
Tax	-1.34	6.53	-0.11	0.02	-0.12	6.33
Equity	34.94	34.94	0	0	32.88	34.94
OPM	2.77	9.21	9.77	9.47	8.32	9.18
Net Profit	3.24-76.0%	21.70	15.76	15.18	13.49	66.13
NPM	1.95	13.17	9.70	9.48	8.25	10.16
EPS	0.93-77.4%	7.33	4.52	4.58	4.12	20.55

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	650.27+8.5%	599.51+4.1%	575.65+15.2%	499.65-2.3%	511.19+30.2%	392.52
Other Income	0.94	3.49	2.99	0.91	1.51	2.40
Total Income	651.21+8.0%	603.01+4.2%	578.64+15.6%	500.56-2.4%	512.69+29.8%	394.92
Expenditure	-587.80-2.5%	-573.46-4.7%	-547.86-7.4%	-510.25-0.5%	-507.93-24.7%	-407.33
Interest	-29.98	-36.95	-29.18	-21.39	-20.61	-23.08
PBDT	0	0	0	0	0	0
EBITDA	106.76+39.9%	76.31+9.0%	70+202.0%	23.18-34.4%	35.32+96.0%	18.02
Depreciation	-14.31	-13.31	-13.03	-12.39	-11.45	-9.75
EBIT	92.45+46.7%	63+10.6%	56.97+428.0%	10.79-54.8%	23.87+188.6%	8.27
PBT	59.80+102.4%	29.55-4.0%	30.78+399.1%	-10.29-112.7%	81.13+753.7%	-12.41
Tax	6.33	0.98	-0.38	-0.11	0.35	-0.20
Equity	34.94	32.77	0	0	0	0
OPM (%)	9.18	4.90	5.00	-2.00	16.00	-3.00
Net Profit	66.13+116.6%	30.53+0.4%	30.40+392.3%	-10.40-112.8%	81.47+746.1%	-12.61
NPM (%)	10.16	5.06	5.00	-2.00	16.00	-3.00
EPS (Rs)	20.55+120.5%	9.32+0.3%	9.29+250.3%	-6.18-124.4%	25.29+601.8%	-5.04
CEPS	19.49	8.98	9.18	-6.18	25.21	-5.04

Metric	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	FY25-26
Revenue	163.18+24.5%	172	133.45	161.19	131.11	650.27
Other Income	0.35	1.84	0.84	1.63	0.94	0.94
Total Income	163.53+23.8%	173.84	134.29	162.82	132.05	651.21
Interest	7.54	9.04	10.17	10.15	7.59	29.98
Expenditure	-149.93-14.4%	-154.79	-133	-154.65	-131.02	-587.80
PBDT	0	0	0	0	0	0
EBITDA	24.43+122.7%	29.62	13.94	20.01	10.97	106.76
Depreciation	-3.64	-3.37	-3.32	-3.32	-3.29	-14.31
EBIT	20.79+170.7%	26.25	10.62	16.69	7.68	92.45
PBT	13.61+1208.7%	19.05	1.29	8.17	1.04	59.80
Tax	-0.12	1.20	-0.07	-0.15	0	6.33
Equity	32.88	32.77	0	32.76	32.75	34.94
OPM	8.32	10.96	0.96	5.02	0.79	9.18
Net Profit	13.49+1197.1%	20.26	1.22	8.02	1.04	66.13
NPM	8.25	11.65	0.91	4.93	0.79	10.16
EPS	4.12+1187.5%	6.18	0.76	2.44	0.32	20.55

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	650.27+8.5%	599.51+4.1%	575.65+15.2%	499.65-2.3%	511.19+30.2%	392.52
Other Income	0.94	3.49	2.99	0.91	1.51	2.40
Total Income	651.21+8.0%	603.01+4.2%	578.64+15.6%	500.56-2.4%	512.69+29.8%	394.92
Expenditure	-587.80-2.5%	-573.46-4.7%	-547.86-7.4%	-510.25-0.5%	-507.93-24.7%	-407.33
Interest	-29.98	-36.95	-29.18	-21.39	-20.61	-23.08
PBDT	0	0	0	0	0	0
EBITDA	106.76+39.9%	76.31+9.0%	70+202.0%	23.18-34.4%	35.32+96.0%	18.02
Depreciation	-14.31	-13.31	-13.03	-12.39	-11.45	-9.75
EBIT	92.45+46.7%	63+10.6%	56.97+428.0%	10.79-54.8%	23.87+188.6%	8.27
PBT	59.80+102.4%	29.55-47.6%	56.34+647.5%	-10.29-112.7%	81.13+753.7%	-12.41
Tax	6.33	0.98	-0.38	-0.11	0.35	-0.20
Equity	34.94	32.77	0	0	0	0
OPM (%)	9.18	4.90	9.74	-2.06	15.82	-3.14
Net Profit	66.13+116.6%	30.53-45.4%	55.96+638.1%	-10.40-112.8%	81.47+746.1%	-12.61
NPM (%)	10.16	5.06	9.67	-2.08	15.89	-3.19
EPS (Rs)	20.55+120.5%	9.32-64.7%	26.39+527.0%	-6.18-124.4%	25.29+601.8%	-5.04
CEPS	19.49	8.98	26.07	-6.18	25.21	-5.04

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2010	Final Dividend	1	29 Jul 2010
2009	Final Dividend	0.5	12 Mar 2009

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split